Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of new Biologics Is Important
Kircik, L.H.
Journal of Drugs in Dermatology Jdd 16(8): S113-S114
2017
ISSN/ISBN: 1545-9616 PMID: 28809999 Document Number: 17226
Increased understanding of psoriasis has led to a shift in treatments from non-specific immunosuppressants to targeted biologics. Studies in psoriasis have demonstrated minimal risk and substantial benefit. As a result, dermatologists and patients are more frequently choosing biologics as first-line treatments for moderate-to-severe disease as our biologics options have recently increased..
Document emailed within 1 workday
Related Documents
Miyachi, Y.; Ohkawara, A.; Ohkido, M.; Harada, S.; Tamaki, K.; Nakagawa, H.; Hori, Y.; Nishiyama, S. 2002: Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris European Journal of Dermatology: Ejd 12(5): 463-468Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866
Ohkubo, M.; Ishimitsu, T.; Kawaguchi, T.; Abe, M.; Yagi, S. 1993: Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia Nihon Jinzo Gakkai Shi 35(2): 171-177
Guillot, B.; Guilhou, J.J.; de Champvallins, M.; Mallet, C.; Moccatti, D.; Pointel, J.P. 1989: A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency International Angiology: a Journal of the International Union of Angiology 8(4 Suppl): 67-71
Skvortsov, A.A.; Mareev, V.Y.; Chelmakina, S.M.; Baklanova, N.A.; Belenkov, I.N. 2007: Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy Kardiologiia 47(10): 12-23
Kragballe, K.; Fogh, K.; Søgaard, H. 1991: Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study Acta Dermato-Venereologica 71(6): 475-478
Reich, K.; Papp, K.A.; Griffiths, C.E.M.; Szapary, P.O.; Yeilding, N.; Wasfi, Y.; Ott, E.; Hsu, M-Chun.; Lebwohl, M.; Gordon, K.B. 2012: An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up Journal of drugs in dermatology: JDD 11(3): 300-312
Miki, T. 2017: Efficacy and safety of long-term bisphosphonate treatment for osteoporosis Clinical Calcium 27(2): 239-246
Patrono, C. 2001: Efficacy and safety of aspirin in the long-term management of atherothrombosis Haematologica 86(11 Suppl 2: 19-21
Patrono, C. 2002: Efficacy and safety of aspirin in the long-term management of atherothrombosis Haematologica 87(1): 6-8
Penston, J.; Wormsley, K.G. 1990: Long-term maintenance therapy in duodenal ulcer. Efficacy and safety Fortschritte der Medizin 108(14): 282-286
Myburgh, D.P. 1990: Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension South African Medical Journal 78(8): 456-457
DEN Dekker, W.K.; VAN Geuns, R.J.; Diletti, R. 2016: Long-term results of BVS implantation: a focus on safety and efficacy of the bioresorbable technology Minerva Cardioangiologica 64(4): 462-472
Shmidt, E.I.; Bilinskaia, M.A.; Belozerova, I.V.; Soldatov, D.G.; Dmitrieva, M.E. 2007: Long-term efficacy and safety of chondroitin sulphate (structum, France) in patients with coxarthrosis Terapevticheskii Arkhiv 79(1): 65-67
Katsiki, N.; Athyros, V.G.; Karagiannis, A.; Mikhailidis, D.P. 2011: Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia International Angiology: a Journal of the International Union of Angiology 30(3): 295; Author Reply 296
Ong, L.M.; Punithavathi, N.; Lena, Y.L.L.; Mahanim, O.; Leekha, S.; Sia, K.K.; Yuhanis, Y.; Khor, B.T.; Adlina, B.; Hema, P.; Ch'ng, S.K.; Letchuman, G.R.; Chia, W.K.; Sim, K.H.; Chin, W.M.; Ong, T.K.; Ang, C.K.; Liew, H.B.; Annuar, R.; Fong, Y.Y.; Yew, K.L.; Yoon, C.K.; Leong, B.; Chandran, K.; Ang, C.L.; Suriani, S.; Koay, B.S.; Ahmad, R.; Ngau, Y.Y.; Narul, A.; Lee, T.S.; Ang, S.F.; Jeyabalan, T. 2011: Long-term efficacy and safety of a generic atorvastatin in usual clinical care setting Medical Journal of Malaysia 66(3): 214-219
Guo, L.-K.; Zhang, C.-X.; Guo, X.-F. 2011: Long-term efficacy and safety research on functional dyspepsia treated with electroacupuncture and Zhizhu Kuanzhong capsule Zhongguo Zhen Jiu 31(12): 1071-1077
Tedeschi, R.E.; Martz, B.L.; Taylor, H.A.; Cerimelle, B.J. 1980: A long-term (9 years) clinical study of the safety and efficacy of probucol, and an analysis of morbidity and mortality rates La Nouvelle Presse Medicale 9(40): 3021-3027
Adler, L.A.; Spencer, T.J.; Williams, D.W.; Moore, R.J.; Michelson, D. 2008: Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study Journal of Attention Disorders 12(3): 248-253
Vorob'eva, N.M.; Panchenko, E.P.; Dobrovol'skiĭ, A.B.; Titaeva, E.V.; Ermolina, O.V.; Balakhonova, T.V.; Khasanova, Z.B.; Postnov, A.I.; Kirienko, A.I. 2011: Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications Terapevticheskii Arkhiv 83(12): 43-48